Cetrelimab Antibody
Cetrelimab (JNJ 63723283) is a humanized anti-PD-1 monoclonal antibody used in oncology research. It enhances T cell activity and cytokine production in a dose-dependent manner, supporting investigations in multiple myeloma and bladder cancer models, both in vitro and in vivo.
Product Specifications
Product Name Alternative
JNJ 3283, JNJ63723283, JNJ 63723283, JNJ3283
Target
PD-1/PD-L1, TNF, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
2.32 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.04 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042503-100 1x 100 µL
CD73 (Immuno-Oncology Target) (NT5E/2503), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472092-100 1x 100 µL
P53 Tumor Suppressor Protein (TP53/2092R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details